• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

mergers and acquisitions

merger MA unit combine consolidate deal
MedTech

Teleflex inks $2B in divestment deals for 3 company units

Montagu and Kohlberg will take Teleflex’s OEM division for $1.5 billion, and Intersurgical will pay $530 million for the acute care and urology units.
Conor Hale Dec 9, 2025 12:26pm
Bluejay

Mirum nets Bluejay and its ph. 3-stage hepatitis drug for $620M

Dec 8, 2025 9:45am
Stryker

Stryker promotes president, COO to help lead its M&A strategy

Dec 8, 2025 9:40am
Laboratory

Natera buys Foresight Diagnostics in $450M cancer testing deal

Dec 5, 2025 11:57am
The headquarters of the US Federal Trade Commission FTC in Washington DC November 18 2024

FTC outlines antitrust case against Edwards' JenaValve deal

Nov 25, 2025 3:10pm
Man with bandage in injured hand

Solventum to buy Acera for up to $850M, repurchase $1B in stock

Nov 24, 2025 9:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings